Updates
Updates on our work to establish “one standard” in the treatment of epilepsy and associated psychiatric disorders around the world.
August 16, 2019
Earlier this year, ROW launched the Amanda Award to honor the memory of Amanda Brooke de los Santos, who passed away from seizures at a young age. Each year, ROW will award a grant to an organization with a track record of achieving meaningful results in addressing untreated epilepsy.
July 17, 2019
Last month our Director of Global Programs, Ken Koskela, visited the CURE Children’s Hospital of Uganda. CURE Uganda (https://cure.org/uganda/) is doing world class work in neurosurgery for very poor patients. Uganda has many cases...
June 20, 2019
Through the generosity of our social enterprise partner, OWP Pharmaceuticals, ROW made a grant of 50 cases of RoweepraXR® (levetiracetam USP) to the West Atlantic Brain and Stroke Foundation. The medicine is headed to their Purple Clinic epilepsy...
May 15, 2019
In 2017, two Loma Linda University Health (LLUH) physicians travelled to Malawi, a country of 18 million in southeastern Africa. They helped install a new EEG system and launch an epilepsy monitoring unit at Malamulo Hospital, a 250-bed facility in rural southern Malawi.
April 30, 2019
We are excited to present our first Annual Program Report. 2018 was an exceptionally exciting year for us and also a year of many “firsts” for the foundation.
March 26, 2019
In keeping with our mission to improve the lives of people living with epilepsy and associated psychiatric disorders in under-resourced regions, we are happy to announce a partnership with The HAPPINESS Project.
February 20, 2019
In January I had the pleasure of traveling with Dr. Jeff Loeb, the Head of the Department of Neurology and Rehabilitation at the University of Illinois at Chicago (UIC), and Dr. Jesica Herrick, an infectious disease doctor at UIC, to the Hospital de Niños in Santa Cruz, Bolivia.
January 15, 2019
The ROW Foundation has donated enough of the antiepileptic drug (AED) Roweepra to cover 63,000 months of treatment. We can’t know for sure how many children and adults in underserved parts of the world are benefiting from our medication grants, but the number is growing rapidly.
December 18, 2018
This has been an exciting year for the ROW Foundation. That makes it difficult deciding what should be the focus of this year-end letter. I’ve settled on three chapters from our 2018 story that make me especially proud and grateful to be part of the ROW Foundation.